OpenURL Connection Search

Select item for more details and to access through your institution.

Skin microbiota signature distinguishes IBD patients and reflects skin adverse events during anti-TNF therapy.
Published in:
Frontiers in Cellular & Infection Microbiology, 2023, v. 12, p. 1, doi. 10.3389/fcimb.2022.1064537
By:
- Reiss, Zuzana;
- Rob, Filip;
- Kolar, Martin;
- Schierova, Dagmar;
- Kreisinger, Jakub;
- Jackova, Zuzana;
- Roubalova, Radka;
- Coufal, Stepan;
- Mihula, Martin;
- Thon, Tomas;
- Bajer, Lukas;
- Novakova, Michaela;
- Vasatko, Martin;
- Kostovcikova, Klara;
- Galanova, Natalie;
- Lukas, Milan;
- Kverka, Miloslav;
- Hercogova, Jana Tresnak;
- Tlaskalova-Hogenova, Helena;
- Zakostelska, Zuzana Jiraskova
Publication type:
Article
Interindividual differences contribute to variation in microbiota composition more than hormonal status: A prospective study.
Published in:
Frontiers in Endocrinology, 2023, v. 14, p. 01, doi. 10.3389/fendo.2023.1139056
By:
- Jackova, Zuzana;
- Stepan, Jan J.;
- Coufal, Stepan;
- Kostovcik, Martin;
- Galanova, Natalie;
- Reiss, Zuzana;
- Pavelka, Karel;
- Wenchich, Laszlo;
- Hruskova, Hana;
- Kverka, Miloslav
Publication type:
Article
Serum TGF-β1 and CD14 Predicts Response to Anti-TNF-α Therapy in IBD.
Published in:
Journal of Immunology Research, 2023, p. 1, doi. 10.1155/2023/1535484
By:
- Coufal, Stepan;
- Kverka, Miloslav;
- Kreisinger, Jakub;
- Thon, Tomas;
- Rob, Filip;
- Kolar, Martin;
- Reiss, Zuzana;
- Schierova, Dagmar;
- Kostovcikova, Klara;
- Roubalova, Radka;
- Bajer, Lukas;
- Jackova, Zuzana;
- Mihula, Martin;
- Drastich, Pavel;
- Tresnak Hercogova, Jana;
- Novakova, Michaela;
- Vasatko, Martin;
- Lukas, Milan;
- Tlaskalova-Hogenova, Helena;
- Jiraskova Zakostelska, Zuzana
Publication type:
Article
Fecal Microbiome Changes and Specific Anti-Bacterial Response in Patients with IBD during Anti-TNF Therapy.
Published in:
Cells (2073-4409), 2021, v. 10, n. 11, p. 3188, doi. 10.3390/cells10113188
By:
- Schierova, Dagmar;
- Roubalova, Radka;
- Kolar, Martin;
- Stehlikova, Zuzana;
- Rob, Filip;
- Jackova, Zuzana;
- Coufal, Stepan;
- Thon, Tomas;
- Mihula, Martin;
- Modrak, Martin;
- Kverka, Miloslav;
- Bajer, Lukas;
- Kostovcikova, Klara;
- Drastich, Pavel;
- Hercogova, Jana;
- Novakova, Michaela;
- Vasatko, Martin;
- Lukas, Milan;
- Tlaskalova-Hogenova, Helena;
- Jiraskova Zakostelska, Zuzana
Publication type:
Article
Inflammatory Bowel Disease Types Differ in Markers of Inflammation, Gut Barrier and in Specific Anti-Bacterial Response.
Published in:
Cells (2073-4409), 2019, v. 8, n. 7, p. 719, doi. 10.3390/cells8070719
By:
- Coufal, Stepan;
- Galanova, Natalie;
- Bajer, Lukas;
- Gajdarova, Zuzana;
- Schierova, Dagmar;
- Jiraskova Zakostelska, Zuzana;
- Kostovcikova, Klara;
- Jackova, Zuzana;
- Stehlikova, Zuzana;
- Drastich, Pavel;
- Tlaskalova-Hogenova, Helena;
- Kverka, Miloslav
Publication type:
Article
Association between ustekinumab therapy and changes in specific anti-microbial response, serum biomarkers, and microbiota composition in patients with IBD: A pilot study.
Published in:
PLoS ONE, 2022, v. 17, n. 12, p. 1, doi. 10.1371/journal.pone.0277576
By:
- Rob, Filip;
- Schierova, Dagmar;
- Stehlikova, Zuzana;
- Kreisinger, Jakub;
- Roubalova, Radka;
- Coufal, Stepan;
- Mihula, Martin;
- Jackova, Zuzana;
- Kverka, Miloslav;
- Thon, Tomas;
- Kostovcikova, Klara;
- Bajer, Lukas;
- Drastich, Pavel;
- Hercogova, Jana Tresnak;
- Novakova, Michaela;
- Kolar, Martin;
- Vasatko, Martin;
- Lukas, Milan;
- Tlaskalova-Hogenova, Helena;
- Jiraskova Zakostelska, Zuzana
Publication type:
Article

Found: 6

Skin microbiota signature distinguishes IBD patients and reflects skin adverse events during anti-TNF therapy.

Interindividual differences contribute to variation in microbiota composition more than hormonal status: A prospective study.

Serum TGF-β1 and CD14 Predicts Response to Anti-TNF-α Therapy in IBD.

Fecal Microbiome Changes and Specific Anti-Bacterial Response in Patients with IBD during Anti-TNF Therapy.

Inflammatory Bowel Disease Types Differ in Markers of Inflammation, Gut Barrier and in Specific Anti-Bacterial Response.

Association between ustekinumab therapy and changes in specific anti-microbial response, serum biomarkers, and microbiota composition in patients with IBD: A pilot study.